Aldose reductase inhibitor, fidarestat prevents doxorubicin-induced endothelial cell death and dysfunction

被引:29
|
作者
Sonowal, Himangshu [1 ]
Pal, Pabitra [1 ]
Shukla, Kirtikar [1 ]
Saxena, Ashish [1 ]
Srivastava, Satish K. [1 ]
Ramana, Kota V. [1 ]
机构
[1] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA
关键词
Aldose reductase; Fidarestat; Doxorubicin; Endothelial cells; Cardiotoxicity; BREAST-CANCER PATIENTS; FACTOR-KAPPA-B; NITRIC-OXIDE; INDUCED CARDIOTOXICITY; INDUCED CARDIOMYOPATHY; COLON-CANCER; MOLECULAR-MECHANISMS; UP-REGULATION; IN-VIVO; INFLAMMATION;
D O I
10.1016/j.bcp.2018.02.018
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Despite doxorubicin (Dox) being one of the most widely used chemotherapy agents for breast, blood and lung cancers, its use in colon cancer is limited due to increased drug resistance and severe cardiotoxic side effects that increase mortality associated with its use at high doses. Therefore, better adjuvant therapies are warranted to improve the chemotherapeutic efficacy and to decrease cardiotoxicity. We have recently shown that aldose reductase inhibitor, fidarestat, increases the Dox-induced colon cancer cell death and reduces cardiomyopathy. However, the efficacy of fidarestat in the prevention of Dox-induced endothelial dysfunction, a pathological event critical to cardiovascular complications, is not known. Here, we have examined the effect of fidarestat on Dox-induced endothelial cell toxicity and dysfunction in vitro and in vivo. Incubation of human umbilical vein endothelial cells (HUVECs) with Dox significantly increased the endothelial cell death, and pre-treatment of fidarestat prevented it. Further, fidarestat prevented the Dox-induced oxidative stress, formation of reactive oxygen species (ROS) and activation of Caspase-3 in HUVECs. Fidarestat also prevented Dox-induced monocyte adhesion to HUVECs and expression of ICAM-1 and VCAM-1. Fidarestat pre-treatment to HUVECs restored the Dox-induced decrease in the Nitric Oxide (NO)-levels and eNOS expression. Treatment of HUVECs with Dox caused a significant increase in the activation of NF-kappa B and expression of various inflammatory cytokines and chemokines which were prevented by fidarestat pre-treatment. Most importantly, fidarestat prevented the Doxinduced mouse cardiac cell hypertrophy and expression of eNOS, iNOS, and 3-Nitrotyrosine in the aorta tissues. Further, fidarestat blunted the Dox-induced expression of various inflammatory cytokines and chemokines in vivo. Thus, our results suggest that by preventing Dox-induced endothelial cytotoxicity and dysfunction, AR inhibitors could avert cardiotoxicity associated with anthracycline chemotherapy.
引用
收藏
页码:179 / 188
页数:10
相关论文
共 50 条
  • [31] Topoisomerase II Inhibitor, Dexrazoxane, Prevents Doxorubicin-Induced DNA Damage
    Roti, Elon C. Roti
    Salih, Sana M.
    JOURNAL OF WOMENS HEALTH, 2010, 19 (10) : 1799 - 1799
  • [32] An aldose reductase inhibitor prevents galactose-induced macroangiopathy in beagle dogs
    Hotta, N
    Kasuya, Y
    Koh, N
    Sakakibara, F
    Nakamura, J
    Hamada, Y
    Hara, T
    Sasaki, H
    Nakashima, E
    Naruse, K
    Kato, K
    Itoh, M
    DIABETOLOGIA, 1996, 39 : 1094 - 1094
  • [33] Regulated cell death pathways in doxorubicin-induced cardiotoxicity
    Effimia Christidi
    Liam R. Brunham
    Cell Death & Disease, 12
  • [34] Plaunotol inhibits doxorubicin-induced renal cell death
    De-Eknamkul, W.
    Chaotham, C.
    Chanvorachote, P.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S172 - S172
  • [35] ALDOSE REDUCTASE INHIBITOR AT-007 PREVENTS MITOCHONDRIAL DYSFUNCTION AND NEURODEGENERATION IN SORBITOL DEHYDROGENASE DEFICIENCY-INDUCED NEUROPATHY
    Zhu, Yi
    Lobato, Amanda
    Rebelo, Adriana
    Canic, Tijana
    Syed, Sheyum
    Perfetti, Riccardo
    Shendelman, Shoshana
    Zuchner, Stephan
    Zhai, Grace
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2022, 27 : S74 - S75
  • [36] Regulated cell death pathways in doxorubicin-induced cardiotoxicity
    Christidi, Effimia
    Brunham, Liam R.
    CELL DEATH & DISEASE, 2021, 12 (04)
  • [37] Amelioration of Acute Kidney Injury in Lipopolysaccharide-Induced Systemic Inflammatory Response Syndrome by an Aldose Reductase Inhibitor, Fidarestat
    Takahashi, Kazunori
    Mizukami, Hiroki
    Kamata, Kosuke
    Inaba, Wataru
    Kato, Noriaki
    Hibi, Chihiro
    Yagihashi, Soroku
    PLOS ONE, 2012, 7 (01):
  • [38] Endothelial Myc Deletion Reduces Doxorubicin-induced Cardiac Dysfunction And Remodeling
    Machi, Jacqueline F.
    Morales, Alejo A.
    Qi, Yue
    Mendez, Nikole Q.
    Schmidt, Augusto F.
    Rodrigues, Claudia O.
    CIRCULATION RESEARCH, 2021, 129
  • [39] ABCB10 Overexpression Prevents Acute Doxorubicin-Induced Cardiac Dysfunction
    Smuder, Ashley J.
    Doerr, Vivian
    Nguyen, Branden L.
    CIRCULATION, 2021, 144
  • [40] Prevention of diabetic ocular complications in spontaneously diabetic Torii rats by aldose reductase inhibitor fidarestat
    Kakehashi, A
    Saito, Y
    Ono, R
    Sugi, N
    Mori, K
    Kuroki, M
    Kawakami, M
    Kanazawa, Y
    Hirooka, H
    Kato, N
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U92 - U92